Paul Kotey

1.7k total citations
17 papers, 813 citations indexed

About

Paul Kotey is a scholar working on Pharmacology, Urology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Paul Kotey has authored 17 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 4 papers in Urology and 4 papers in Anesthesiology and Pain Medicine. Recurrent topics in Paul Kotey's work include Inflammatory mediators and NSAID effects (8 papers), Pain Management and Opioid Use (4 papers) and Menstrual Health and Disorders (4 papers). Paul Kotey is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Pain Management and Opioid Use (4 papers) and Menstrual Health and Disorders (4 papers). Paul Kotey collaborates with scholars based in United States, Germany and Japan. Paul Kotey's co-authors include Kerstin Malmström, Paul J. Desjardins, Stephen Daniels, Beth C. Seidenberg, James R. Fricke, Briggs Morrison, Rebecca Redman, Koné Kaniga, David A. Whiting and R Savin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Academy of Dermatology and Obstetrics and Gynecology.

In The Last Decade

Paul Kotey

17 papers receiving 765 citations

Peers

Countries citing papers authored by Paul Kotey

Since Specialization

Citations

This map shows the geographic impact of Paul Kotey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Kotey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Kotey more than expected).

Fields of papers citing papers by Paul Kotey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Kotey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Kotey. The network helps show where Paul Kotey may publish in the future.

Co-authorship network of co-authors of Paul Kotey

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Kotey. A scholar is included among the top collaborators of Paul Kotey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Kotey. Paul Kotey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Intravenous Doripenem for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis 2010 ·Journal of Chemotherapy ·Rebecca Redman, Ronaldo Damião, Paul Kotey, Koné Kaniga, Todd A. Davies, (unknown)	11
2	Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis 2009 ·Antimicrobial Agents and Chemotherapy ·Kurt G. Naber, Lily Llorens, Koné Kaniga, Paul Kotey, (unknown), Rebecca Redman	61
3	MK-0703 (a Cyclooxygenase-2 inhibitor) in Acute Pain Associated with Dental Surgery: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Dose-Ranging Study 2007 ·American Journal of Therapeutics ·Jules I. Schwartz, Paul Kotey, James R. Fricke, Keith Gottesdiener	6
4	P833 Intravenous therapy with doripenem versus levofioxacin with an option for oral step-down therapy in the treatment of complicated urinary tract infections and pyelonephritis 2007 ·International Journal of Antimicrobial Agents ·Kurt G. Naber, Rebecca Redman, Paul Kotey, Lily Llorens, Koné Kaniga	14
5	Dental Impaction Pain Model as a Potential Tool to Evaluate Drugs With Efficacy in Neuropathic Pain 2006 ·The Journal of Clinical Pharmacology ·Kerstin Malmström, Paul Kotey, (unknown), Rohini Ramakrishnan, Keith Gottesdiener, Alise Reicin, John A. Wagner	4
6	Etoricoxib Provides Analgesic Efficacy to Patients After Knee or Hip Replacement Surgery: A Randomized, Double-Blind, Placebo-Controlled Study 2005 ·Anesthesia & Analgesia ·G. Lynn Rasmussen, Kerstin Malmström, Michael H. Bourne, Maurice Jové, Steven M. Rhondeau, Paul Kotey, (unknown), (unknown), Alise Reicin	44
7	Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: A randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model 2004 ·Clinical Therapeutics ·Russell Scott, (unknown), Paul Kotey, James R. Fricke	33
8	A Randomized, Double-Blind, Parallel-Group Study Comparing the Analgesic Effect of Etoricoxib to Placebo, Naproxen Sodium, and Acetaminophen With Codeine Using the Dental Impaction Pain Model 2004 ·Clinical Journal of Pain ·Kerstin Malmström, Paul Kotey, (unknown), Paul J. Desjardins	57
9	Analgesic Efficacy of Etoricoxib in Primary Dysmenorrhea: Results of a Randomized, Controlled Trial 2003 ·Gynecologic and Obstetric Investigation ·Kerstin Malmström, Paul Kotey, N. Cichanowitz, Stephen Daniels, Paul J. Desjardins	40
10	ROFECOXIB COMPARED TO OXYCODONE/ACETAMINOPHEN FOR POSTOPERATIVE DENTAL PAIN 2002 ·Pain Medicine ·James R. Fricke, (unknown), (unknown), Paul Kotey, Russell Scott	1
11	A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: A single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model 2002 ·Clinical Therapeutics ·Kerstin Malmström, James R. Fricke, Paul Kotey, (unknown), Briggs Morrison	56
12	Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia 2000 ·Journal of the American Academy of Dermatology ·Vera H. Price, Janet L. Roberts, Maria Hordinsky, Elise A. Olsen, R Savin, Wilma F. Bergfeld, Virginia C. Fiedler, Anne W. Lucky, David A. Whiting, Frances Pappas, Jennifer Culbertson, Paul Kotey, Alan G. Meehan, Joanne Waldstreicher	197
13	THE OPTIMAL ANALGESIC DOSE OF ROFECOXIB: OVERVIEW OF SIX RANDOMIZED CONTROLLED TRIALS 2000 ·The Journal of the American Dental Association ·Briggs Morrison, James R. Fricke, J. Brown, Wei Yuan, Paul Kotey, Donald R. Mehlisch	44
14	Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial 1999 ·Clinical Therapeutics ·Kerstin Malmström, Stephen Daniels, Paul Kotey, Beth C. Seidenberg, Paul J. Desjardins	219
15	Rofecoxib, a Specific Cyclooxygenase-2 Inhibitor, in Primary Dysmenorrhea 1999 ·Obstetrics and Gynecology ·Briggs Morrison, Stephen E. Daniels, Paul Kotey, (unknown), Beth C. Seidenberg	8
16	The COX-2 specific inhibitor, MK-0966, is effective in the treatment of primary dysmenorrhea 1999 ·Clinical Pharmacology & Therapeutics ·J. C. Brown, Barclay Morrison, (unknown), (unknown), M. Sandler, (unknown), Paul Kotey, (unknown)	10
17	Dose ranging trial of the effect of MK-966 in primary dysmenorrhea 1999 ·Clinical Pharmacology & Therapeutics ·S. Daniels, Barclay Morrison, (unknown), M. Sandler, (unknown), Paul Kotey, Beth C. Seidenberg	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact